Anh Duong

Anh Duong has been working in the field of research and development for over 30 years. Anh began their career in 1991 as a Senior Professional at Neocrin Company. In 2002, they joined Allergan, Inc. as a Research Scientist. Anh was instrumental in the Inflammation Research Program of the Ocular Surface for 10 years, leading to the FDA approved immunosuppressive agent used to treat chronic dry eye disease, Restasis. From 2009 to 2012, they held the role of Scientist and Senior Professional in the same company. In 2016, they joined Edwards Lifesciences as a Senior Biologist. In 2018, they became the Research Laboratory Manager at the Translational Pulmonary and Immunology Research Center.

Anh Duong has a Bachelor's Degree from the University of Pittsburgh Pennsylvania.